Glioblastoma multiforme (GBM) is the most common and lethal of adult gliomas. The prognosis for the great majority of patients with GBM is poor as almost all tumors recur following optimal ...
Her mother Nicola Nuttall said it was "really special" to finish on her daughter's birthday. She told BBC North West Tonight ...
Genomic profiling enables personalized cancer treatments, improving survival and quality of life; precision oncology holds ...
Then my radiation oncologist asked if I’d be interested in trying a medical device called Optune® for the treatment of glioblastoma multiforme (GBM) and walked me through the risks and benefits.
FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Optune Gio® for Glioblastoma
Optune Gio is a wearable, portable, FDA-approved device indicated to treat a type of brain cancer called glioblastoma multiforme (GBM) in adult patients 22 years of age or older. Newly diagnosed ...
Ottawa, Nov. 25, 2024 (GLOBE NEWSWIRE) -- The global glioblastoma multiforme treatment market size is predicted to increase from USD 3.01 billion in 2025 to approximately USD 5.68 billion by 2033, ...
Lori Nickel: Paul Maurer shows what it means to keep going despite the ‘darkness’ of rare cancer
He a 65-year-old man, once capable of cycling 250 miles in a day, now living with Glioblastoma Multiforme, an aggressive brain tumor that has begun to jumble his thoughts and his speech.
Over the years, the Head for the Cure 5k in San Antonio has given participants a way to honor and remember their loved ones, ...
New treatment approach with proton beam therapy for glioblastoma improves survival rates and quality of life for older ...
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor, with an expected median progression-free survival (PFS) of 6.9 months and median overall survival (OS) of 10–14 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback